Reported Earnings • Jul 13
Second quarter 2026 earnings released: EPS: JP¥200 (vs JP¥301 in 2Q 2025) Second quarter 2026 results: EPS: JP¥200 (down from JP¥301 in 2Q 2025). Revenue: JP¥2.29b (down 3.8% from 2Q 2025). Net income: JP¥179.0m (down 34% from 2Q 2025). Profit margin: 7.8% (down from 11% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Board Change • May 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. 2 independent directors (6 non-independent directors). Independent Outside Director Kiyoshi Takayama was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Sep 06
Sankei Chemical Co., Ltd. announces Annual dividend, payable on February 27, 2026 Sankei Chemical Co., Ltd. announced Annual dividend of JPY 25.0000 per share payable on February 27, 2026, ex-date on November 27, 2025 and record date on November 30, 2025. Announcement • Feb 17
Sankei Chemical Co., Ltd., Annual General Meeting, Feb 26, 2025 Sankei Chemical Co., Ltd., Annual General Meeting, Feb 26, 2025, at 11:00 Tokyo Standard Time. Location: 2-9 minamisakae, kagoshima city sankei chemical co., 2nd floor conference room, kagoshima city Japan Reported Earnings • Oct 15
Third quarter 2024 earnings released: JP¥70.28 loss per share (vs JP¥82.88 loss in 3Q 2023) Third quarter 2024 results: JP¥70.28 loss per share (improved from JP¥82.88 loss in 3Q 2023). Revenue: JP¥1.18b (up 4.6% from 3Q 2023). Net loss: JP¥63.0m (loss narrowed 19% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 16
Second quarter 2024 earnings released: EPS: JP¥230 (vs JP¥198 in 2Q 2023) Second quarter 2024 results: EPS: JP¥230 (up from JP¥198 in 2Q 2023). Revenue: JP¥2.15b (down 1.7% from 2Q 2023). Net income: JP¥206.0m (up 11% from 2Q 2023). Profit margin: 9.6% (up from 8.5% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to JP¥1,525, the stock trades at a trailing P/E ratio of 21x. Average trailing P/E is 14x in the Chemicals industry in Japan. Total returns to shareholders of 58% over the past three years. Reported Earnings • Apr 10
First quarter 2024 earnings released: EPS: JP¥18.07 (vs JP¥12.52 loss in 1Q 2023) First quarter 2024 results: EPS: JP¥18.07 (up from JP¥12.52 loss in 1Q 2023). Revenue: JP¥1.23b (down 7.2% from 1Q 2023). Net income: JP¥17.0m (up JP¥29.0m from 1Q 2023). Profit margin: 1.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. New Risk • Mar 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (JP¥1.21b market cap, or US$7.96m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.4% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin). Announcement • Mar 07
Sankei Chemical Co., Ltd. (FKSE:4995) announces an Equity Buyback for 50,000 shares, representing 5.31% for ¥58.85 million. Sankei Chemical Co., Ltd. (FKSE:4995) announces a share repurchase program. Under the program, the company will repurchase 50,000 shares, representing 5.31% of the outstanding shares, for ¥58.85 million. The shares will be repurchased at a price of ¥1,177 per share. The purpose of the program is to improve capital efficiency and implement a flexible capital policy that responds to future changes in the business environment. As of February 29, 2024, the company had 941,040 shares outstanding (excluding treasury stock) and 78,660 shares in treasury. Reported Earnings • Jan 17
Full year 2023 earnings released: EPS: JP¥38.08 (vs JP¥221 in FY 2022) Full year 2023 results: EPS: JP¥38.08 (down from JP¥221 in FY 2022). Revenue: JP¥6.00b (down 17% from FY 2022). Net income: JP¥36.0m (down 83% from FY 2022). Profit margin: 0.6% (down from 2.9% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Upcoming Dividend • Nov 23
Upcoming dividend of JP¥30.00 per share at 2.5% yield Eligible shareholders must have bought the stock before 29 November 2023. Payment date: 27 February 2024. Payout ratio is a comfortable 75% but the company is not cash flow positive. Trailing yield: 2.5%. Lower than top quartile of Japanese dividend payers (3.4%). In line with average of industry peers (2.4%). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Outside Director Kiyoshi Takayama was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Oct 11
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 45% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (JP¥1.10b market cap, or US$7.40m). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin). Board Change • Aug 08
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent Outside Director Kiyoshi Takayama was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Jul 16
Second quarter 2023 earnings released: EPS: JP¥198 (vs JP¥191 in 2Q 2022) Second quarter 2023 results: EPS: JP¥198 (up from JP¥191 in 2Q 2022). Revenue: JP¥2.18b (down 3.8% from 2Q 2022). Net income: JP¥186.0m (up 1.6% from 2Q 2022). Profit margin: 8.5% (up from 8.1% in 2Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 5% per year. Reported Earnings • Apr 11
First quarter 2023 earnings released: JP¥12.52 loss per share (vs JP¥75.13 profit in 1Q 2022) First quarter 2023 results: JP¥12.52 loss per share (down from JP¥75.13 profit in 1Q 2022). Revenue: JP¥1.32b (down 20% from 1Q 2022). Net loss: JP¥12.0m (down 117% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 05
Full year 2022 earnings released: EPS: JP¥221 (vs JP¥327 in FY 2021) Full year 2022 results: EPS: JP¥221 (down from JP¥327 in FY 2021). Revenue: JP¥7.24b (up 3.0% from FY 2021). Net income: JP¥212.0m (down 32% from FY 2021). Profit margin: 2.9% (down from 4.5% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 14
Full year 2022 earnings released: EPS: JP¥221 (vs JP¥327 in FY 2021) Full year 2022 results: EPS: JP¥221 (down from JP¥327 in FY 2021). Revenue: JP¥7.24b (up 3.0% from FY 2021). Net income: JP¥212.0m (down 32% from FY 2021). Profit margin: 2.9% (down from 4.5% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Board Change • Dec 17
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Upcoming Dividend • Nov 22
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 29 November 2022. Payment date: 24 February 2023. Payout ratio is a comfortable 9.9% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.7%). Lower than average of industry peers (2.8%). Board Change • Nov 16
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Oct 14
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 08
Third quarter 2022 earnings released: EPS: JP¥15.65 (vs JP¥78.26 in 3Q 2021) Third quarter 2022 results: EPS: JP¥15.65 (down from JP¥78.26 in 3Q 2021). Revenue: JP¥1.48b (down 4.5% from 3Q 2021). Net income: JP¥15.0m (down 80% from 3Q 2021). Profit margin: 1.0% (down from 4.8% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Board Change • Sep 07
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Aug 11
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Jul 13
Second quarter 2022 earnings released: EPS: JP¥191 (vs JP¥178 in 2Q 2021) Second quarter 2022 results: EPS: JP¥191 (up from JP¥178 in 2Q 2021). Revenue: JP¥2.27b (down 1.9% from 2Q 2021). Net income: JP¥183.0m (up 7.0% from 2Q 2021). Profit margin: 8.1% (up from 7.4% in 2Q 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • May 17
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. No independent directors (8 non-independent directors). Director Kiyoshi Takayama was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Apr 13
First quarter 2022 earnings released: EPS: JP¥75.13 (vs JP¥99.11 in 1Q 2021) First quarter 2022 results: EPS: JP¥75.13 (down from JP¥99.11 in 1Q 2021). Revenue: JP¥1.65b (up 9.0% from 1Q 2021). Net income: JP¥72.0m (down 24% from 1Q 2021). Profit margin: 4.4% (down from 6.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 12
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: JP¥327 (up from JP¥152 in FY 2020). Revenue: JP¥7.03b (up 4.8% from FY 2020). Net income: JP¥313.0m (up 114% from FY 2020). Profit margin: 4.5% (up from 2.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Nov 22
Upcoming dividend of JP¥19.00 per share Eligible shareholders must have bought the stock before 29 November 2021. Payment date: 26 February 2022. Trailing yield: 1.4%. Lower than top quartile of Japanese dividend payers (3.2%). Lower than average of industry peers (2.1%). Reported Earnings • Oct 08
Third quarter 2021 earnings released: EPS JP¥78.26 (vs JP¥8.35 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥1.55b (up 7.7% from 3Q 2020). Net income: JP¥75.0m (up JP¥83.0m from 3Q 2020). Profit margin: 4.8% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 25% share price gain to JP¥1,482, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 55% over the past three years. Reported Earnings • Jul 15
Second quarter 2021 earnings released: EPS JP¥178 (vs JP¥156 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥2.32b (up 6.2% from 2Q 2020). Net income: JP¥171.0m (up 14% from 2Q 2020). Profit margin: 7.4% (up from 6.9% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 14
First quarter 2021 earnings released: EPS JP¥99.11 (vs JP¥7.30 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥1.52b (up 7.7% from 1Q 2020). Net income: JP¥95.0m (up JP¥88.0m from 1Q 2020). Profit margin: 6.3% (up from 0.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 03
Full year 2020 earnings released: EPS JP¥152 (vs JP¥135 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: JP¥6.71b (flat on FY 2019). Net income: JP¥146.0m (up 13% from FY 2019). Profit margin: 2.2% (up from 1.9% in FY 2019). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • Feb 24
Sankei Chemical Co., Ltd., Annual General Meeting, Feb 25, 2021 Sankei Chemical Co., Ltd., Annual General Meeting, Feb 25, 2021. Reported Earnings • Jan 14
Full year 2020 earnings released: EPS JP¥152 The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: JP¥6.71b (flat on FY 2019). Net income: JP¥146.0m (up 13% from FY 2019). Profit margin: 2.2% (up from 1.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Is New 90 Day High Low • Jan 13
New 90-day high: JP¥1,010 The company is up 5.0% from its price of JP¥960 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Upcoming Dividend • Nov 20
Upcoming Dividend of JP¥18.00 Per Share Will be paid on the 21st of February to those who are registered shareholders by the 27th of November. The trailing yield of 1.9% is below the top quartile of Japanese dividend payers (3.1%), and is lower than industry peers (2.1%). Is New 90 Day High Low • Oct 12
New 90-day high: JP¥1,010 The company is up 6.0% from its price of JP¥951 on 14 July 2020. The Japanese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 9.0% over the same period. Reported Earnings • Oct 10
Third quarter earnings released Over the last 12 months the company has reported total profits of JP¥136.0m, up 78% from the prior year. Total revenue was JP¥6.71b over the last 12 months, up 1.6% from the prior year. 
